oncology

Cancer has traditionally been viewed as a non-communicable disease—one driven by genetic predisposition, environmental exposure, and lifestyle factors. Yet a substantial and increasingly compelling body of epidemiological research has shown that a significant proportion of cancers are caused by infectious…

China’s oncologists want to see robust evidence before putting their faith in traditional remedies. Practitioners of traditional Chinese medicine struggle with concepts of experimental medicine and animal models. But interest is growing in finding ways to bridge that gap in…

A new, innovative pipeline fusing genomics, proteomics and modelling in animals and chicken eggs is pinpointing new treatments for children with rare and relapsed cancers in Canada. Researchers in Canada have used fertilized chicken eggs to grow tumors from children…

The gut microbiota can transform cholesterol-derived bile acids into metabolites capable of blocking androgen receptors and strengthening anti-cancer immunity. The study, published in Cell, April 15, demonstrates how one of the microbiota-derived secondary bile acids is capable of suppressing tumour…

Cancer is a word no parent ever wants to hear. But when that word comes with no access to treatment, it doesn’t just hurt—it destroys hope.A year ago, I was walking through a coastal town in Africa. It was a…

Experience gained over decades of tackling cancer and supporting patients in Africa’s most populous country gives Zainab Shinkafi-Bagudu unique insights and influence to help bring about progress in similar settings across the globe. She talked to CancerWorld journalist, Diana Mwango,…

At CancerWorld, we don’t just publish science, we publish stories. As Alberto Costa, reminds us: CancerWorld is not about papers, it’s about people. The June, 2025 issue brings that philosophy into sharp focus. On our dual cover, we feature two…

"One must imagine Sisyphus happy" Albert Camus Why me? This is probably the present-day question of every patient with cancer!  One of the consequences of our chaotic reality is cancer, which belongs to that class of diseases that impacts the…

What does it take to change the odds in cancer care? Innovation? Yes. But also: persistence. Collaboration. The refusal to accept that some lives matter less because of where they’re born. In this issue of CancerWorld, we focus not just…

I grew up around a lot of physicians,” begins Adrian Gottschalk, President and CEO of Foghorn Therapeutics, a biotech company redefining how we understand and treat complex diseases by targeting the chromatin regulatory system. “My late father was a professor…